Recurrent invasive meningococcal infections – quantifying the risk, Germany, 2002 to 2018

Published on June 26, 2020

Patients surviving Invasive Meningococcal disease (IMD) were at least at a 50-fold risk of another IMD episode compared with the general population. The study most likely underestimated the risk of recurrent infection. Increased risk may be due to undiagnosed complement deficiencies. The high risk of re-infection argues for vaccination of patients who have survived IMD. Eurosurveillance

Other news

Notes from the Field: E-cigarette, or Vaping, Product Use-Associated Lung Injury Cases During the COVID-19 Response - California, 2020

June 25, 2020
This report describes eight patients hospitalized with e-cigarette, or vaping, product use-associated lung injury and reported to the California Department of Public Health in April 2020 during the early coronavirus disease 2019 pandemic.

Pre-conference: 1st WHO Infodemiology Conference

June 26, 2020
The pre-conference is open to the public.  Experts will engage with the public with 7 inspiring talks on how the infodemic affects the world currently and reflections how it can be managed. WHO